Literature DB >> 8839549

Surgically defined prognostic parameters in patients with early cervical carcinoma. A multivariate survival tree analysis.

B U Sevin1, Y Lu, D A Bloch, M Nadji, O R Koechli, H E Averette.   

Abstract

BACKGROUND: This study was performed to identify a statistical combination of independent pathologic and clinical features that best predict 5-year disease free survival (DFS) in patients with early stage cervical carcinoma treated by radical hysterectomy. The main goal of the study was to identify subsets of patients based on risk factors with maximal differences in DFS.
METHODS: Three hundred and seventy patients were found for whom complete clinical and pathologic material, including cone and cervical biopsies, were available for analysis. Variables studied included age, weight, race, marital status, economic status, tumor size (TS), depth of invasion (DI), lymph-vascular space involvement (LVSI), cell type, tumor grade, lymph node metastasis (LNM), and number of lymph nodes removed. Patients with LNM, parametrial involvement, and positive or close surgical margins were offered postoperative radiation. After excluding patients with microinvasive and small cell carcinoma, data from the remaining 301 patients were submitted to univariate and multivariate analyses to define those variables that best predict DFS.
RESULTS: Univariate analysis showed that, ranked by degree of significance, DI, TS, LVSI, LNM, tumor volume (TV) and clinical stage were significant in predicting survival. Significant (P < 0.05) single parameters and other variables considered important were chosen for multivariate analysis, including the creation of a survival tree. With this method, DI (< or = 6 mm and > 2 cm), LVSI, age (> or = 40 yrs), and LNM were found to be the best combination of risk factors to define prognosis.
CONCLUSIONS: The multivariate survival tree analysis maximally separates patients with early stage invasive carcinoma of the cervix into 3 subgroups with 5-year DFS of 91%, 68%, and 43%, respectively. The authors excluded patients with microinvasive carcinoma (SGO, Society of Gynecologic Oncologists), who have an excellent DFS of 100%, and patients with small carcinoma, who have a poor DFS of 36.4% based on cell type alone, to define independent risk factors that maximally separate the remaining patients by DSF. The survival tree prognostic scoring system is easy to apply, and only requires DI (mm), LVSI (+, -), LNM, and age to assign an individual patient to one of three risk groups.

Entities:  

Mesh:

Year:  1996        PMID: 8839549     DOI: 10.1002/(SICI)1097-0142(19961001)78:7<1438::AID-CNCR10>3.0.CO;2-0

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  28 in total

1.  Multi-parametric MRI in cervical cancer: early prediction of response to concurrent chemoradiotherapy in combination with clinical prognostic factors.

Authors:  Wei Yang; Jin Wei Qiang; Hai Ping Tian; Bing Chen; Ai Jun Wang; Jian Guo Zhao
Journal:  Eur Radiol       Date:  2017-08-04       Impact factor: 5.315

2.  Brachytherapy and survival in small cell cancer of the cervix and uterus.

Authors:  Alexander J Lin; Comron Hassanzadeh; Stephanie Markovina; Julie Schwarz; Perry Grigsby
Journal:  Brachytherapy       Date:  2018-12-15       Impact factor: 2.362

3.  Prognostic significance of positive lymph node number in early cervical cancer.

Authors:  Jung-Woo Park; Jong Woon Bae
Journal:  Mol Clin Oncol       Date:  2016-03-30

4.  Adjuvant radiochemotherapy in patients with locally advanced high-risk cervical cancer.

Authors:  F Heinzelmann; G Henke; M von Grafenstein; N Weidner; F Paulsen; A Staebler; S Brucker; M Bamberg; M Weinmann
Journal:  Strahlenther Onkol       Date:  2012-05-23       Impact factor: 3.621

5.  Long-term outcomes of postoperative taxane/platinum chemotherapy for early stage cervical cancer: a retrospective study.

Authors:  Mika Okazawa-Sakai; Takanori Yokoyama; Etsuko Fujimoto; Shinichi Okame; Yuko Shiroyama; Takashi Yokoyama; Kazuhiro Takehara
Journal:  Int J Clin Oncol       Date:  2018-02-14       Impact factor: 3.402

6.  Sentinel lymph node biopsy in the management of early-stage cervical carcinoma.

Authors:  John P Diaz; Mary L Gemignani; Neeta Pandit-Taskar; Kay J Park; Melissa P Murray; Dennis S Chi; Yukio Sonoda; Richard R Barakat; Nadeem R Abu-Rustum
Journal:  Gynecol Oncol       Date:  2011-01-08       Impact factor: 5.482

Review 7.  Postoperative radiation therapy for carcinoma of the uterine cervix.

Authors:  Takashi Uno; Koichi Isobe; Seiji Yamamoto; Tetsuya Kawata; Hisao Ito
Journal:  Radiat Med       Date:  2006-02

8.  The annual recurrence risk model for tailored surveillance strategy in patients with cervical cancer.

Authors:  David Cibula; Lukáš Dostálek; Jiri Jarkovsky; Constantijne H Mom; Aldo Lopez; Henrik Falconer; Anna Fagotti; Ali Ayhan; Sarah H Kim; David Isla Ortiz; Jaroslav Klat; Andreas Obermair; Fabio Landoni; Juliana Rodriguez; Ranjit Manchanda; Jan Kosťun; Ricardo Dos Reis; Mehmet M Meydanli; Diego Odetto; Rene Laky; Ignacio Zapardiel; Vit Weinberger; Klára Benešová; Martina Borčinová; Darwin Pari; Sahar Salehi; Nicolò Bizzarri; Huseyin Akilli; Nadeem R Abu-Rustum; Rosa A Salcedo-Hernández; Veronika Javůrková; Jiří Sláma; Luc R C W van Lonkhuijzen
Journal:  Eur J Cancer       Date:  2021-10-16       Impact factor: 10.002

9.  Perineural invasion in early-stage cervical cancer and its relevance following surgery.

Authors:  Yi Zhu; Guonan Zhang; Yan Yang; Ling Cui; Shijun Jia; Yu Shi; Shuiqin Song; Shiqiang Xu
Journal:  Oncol Lett       Date:  2018-02-26       Impact factor: 2.967

10.  Feasibility and effectiveness of postoperative adjuvant concurrent chemoradiation therapy in Japanese patients with high-risk early-stage cancer of the uterine cervix.

Authors:  Kiyosumi Shibata; Hiroaki Kajiyama; Mikio Terauchi; Eiko Yamamoto; Kazuhiko Ino; Akihiro Nawa; Fumitaka Kikkawa
Journal:  Int J Clin Oncol       Date:  2008-06-14       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.